ENVALITH
荏原実業株式会社 logo

EBARA JITSUGYO CO.,LTD.

6328Prime MarketMachinery

荏原実業株式会社 logo
EBARA JITSUGYO CO.,LTD.6328

Manufacturing Business

Core business responsible for in-house development, fabless manufacturing, and sales of environmental products

PeriodCurrentPreviousChange
Sales (Q1 FY2026, ending December 2026)¥2,244 million¥2,276 million
Segment profit (Q1 FY2026, ending December 2026)¥544 million¥582 million
Segment profit margin (Q1 FY2026, ending December 2026)24.2%25.6%
Orders received (Q1 FY2026, ending December 2026)¥4,482 millionup 381.9% year on year
Order backlog (end of Q1 FY2026, ending December 2026)¥6,993 millionup 192.1% year on year

Business Details

A fabless business that outsources production of in-house developed products—such as ozone concentration meters, deodorizing systems, energy-saving blowers, water treatment equipment, infectious disease control products, and residential storage battery systems (ZEB/ZEH-related)—to partner companies for sale. The segment also handles planning, design, and construction of private-sector wastewater treatment facilities, aquaculture-related facilities, and water landscape facilities. It maintains both public and private sector channels, and under the medium-term management plan "EJ2027," positions "disaster prevention/mitigation," "storage batteries," and "fisheries" as priority focus areas.

Recent Overview

Orders received surged 281.9% year on year, while sales and profit saw a slight decline

In Q1 FY2026 (ending December 2026), the company received a large-scale order for land-based aquaculture equipment in the water treatment plant field, and sanitary equipment for public sector clients also grew in the medical field, resulting in a sharp expansion of orders received to ¥4,482 million (up 281.9% year on year). The order backlog also grew to ¥6,993 million (up 192.1% year on year). Meanwhile, although the deodorizing field increased, sales declined in the water treatment plant and medical fields, resulting in sales of ¥2,244 million (down 1.4% year on year) and segment profit of ¥544 million (down 6.6% year on year).

Key Products

product
Ozone Application Equipment & Deodorizing Systems

In Q1 FY2026 (ending December 2026), the deodorizing field increased. This is a core category of in-house developed products manufactured and sold via the fabless model.

product
Water Treatment Equipment & Water Treatment Plants

In Q1 FY2026 (ending December 2026), a large-scale order for land-based aquaculture equipment was received in the water treatment plant field. However, sales decreased year on year.

product
ZEB/ZEH-related Products (Residential Storage Battery Systems)

This product group is positioned within the "storage batteries" priority focus area of the medium-term management plan "EJ2027."

product
Infectious Disease Control Products & Aquaculture/Fisheries Equipment

In Q1 FY2026 (ending December 2026), sanitary equipment for the medical field aimed at public sector clients contributed to increased orders. However, sales decreased year on year.

Growth Drivers

  • Receipt of large-scale orders such as land-based aquaculture equipment in the water treatment plant field (order backlog has grown to ¥6,993 million, up 192.1% year on year, expected to contribute to future sales)
  • Revenue contribution from increased sales in the deodorizing field
  • Strategic investment in priority focus areas of the medium-term management plan "EJ2027" (disaster prevention/mitigation, storage batteries, fisheries)
  • Expansion of orders in the medical field, including sanitary equipment for public sector clients
  • Steady trends in demand for renewal/development of water infrastructure and disaster prevention/mitigation in the public sector

Risks

  • Sales in the water treatment plant and medical fields declined year on year, creating short-term earnings volatility risk due to timing gaps in recognizing revenue from large-scale orders
  • Segment profit margin declined from 25.6% in the same period last year to 24.2%, reflecting downward pressure from factors such as increased fixed costs
  • Production dependency risk on partner companies under the fabless model (supply constraints, cost pass-through risk)
  • Risk of future-period order leveling (rebound decline risk) due to concentration of large-scale order receipts
  • Impact of economic uncertainty stemming from Middle East conditions and trade policies of various countries on private-sector capital investment

Last updated: March 9, 2026